- BASF will divest its Nutrilife® baking enzymes business to Lallemand's subsidiary, Danstar Ferment AG.
- The transaction is expected to complete on September 30, 2022.
- Lallemand recently entered the enzyme development and production sector.
- Lallemand operates in over 50 countries with more than 45 production plants.
Transaction Overview
BASF has entered into a binding agreement with Lallemand Inc’s subsidiary, Danstar Ferment AG, to divest its Nutrilife® baking enzymes portfolio and business. The transaction is expected to complete on September 30, 2022, subject to customary closing conditions.
Strategic Fit
According to Michael de Marco, BASF’s Vice President of Global Business Management Enzymes, the baking enzymes business is not a strategic fit for BASF. Lallemand has been identified as a suitable partner to continue and strengthen the Nutrilife® baking enzymes business, ensuring a reliable supply for customers. BASF will support the transaction to ensure a smooth handover.
Lallemand's Expansion
Lallemand has recently ventured into the development and production of enzymes. The acquisition of the Nutrilife® baking enzymes portfolio will broaden their product offerings and expand their geographical footprint. Lars Asferg, President of Lallemand Bio-Ingredients, expressed enthusiasm about providing Nutrilife® customers with enzyme expertise and innovative ingredients based on Lallemand’s yeast and bacteria technology platforms.
